Therapeutics Inc.
Oleg Khatsenko is an experienced professional in the field of drug metabolism and pharmacokinetics (DMPK) with a career spanning over two decades. Currently serving as a Clinical Project Manager and Director at Leaders in DMPK and Clinical Pharmacology since April 2013, Oleg has also held senior roles with Therapeutics Inc. and Ugichem GmbH. Previous positions include Senior Scientist roles at Regulus Therapeutics and Celgene, as well as consultancy in clinical pharmacokinetics. Oleg's extensive expertise encompasses pharmacokinetics, ADME, bioanalytics of large molecules, and small molecule drug discovery. Oleg holds a Ph.D. in Biochemical Pharmacology from both Oxford Brookes University and William Harvey Research Institute, along with an MSc in Biochemistry from Novosibirsk State University.
Therapeutics Inc.
Therapeutics Inc. is a drug research and development company focusing on integration of clinical and regulatory strategies, trial design, product development, and marketplace analysis. The company’s services include clinical development project management, medical monitoring, and non-clinical development such as designing and managing pharmacology and toxicology programs. Therapeutics develops drugs and devices for acne, psoriasis, melasma, excess facial hair, injectable fillers, photoaging, and onychomycosis. The company was founded in 1997 and is headquartered in San Diego, California.